UBUT:XETRA:XETRA-UBS (Irl) ETF plc - Factor MSCI USA Quality UCITS ETF (USD) A-dis (EUR)

ETF | Others |

Last Closing

USD 39.67

Change

-2.14 (-5.11)%

Market Cap

N/A

Volume

0.03M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-09 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

+0.53 (+1.23%)

USD 100.65B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.92 (-1.02%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.44 (+2.00%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

+0.17 (+1.39%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

+0.07 (+1.42%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

+0.19 (+0.87%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

-0.17 (-1.45%)

USD 23.49B
PPFB:XETRA iShares Physical Gold ETC EUR

-0.42 (-0.74%)

USD 20.66B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

-0.08 (-0.82%)

USD 12.74B
EUN5:XETRA iShares Core Corporate Bond UC..

+0.32 (+0.27%)

USD 12.26B

ETFs Containing UBUT:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -22.22% 11% F 13% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -22.22% 13% F 14% F
Trailing 12 Months  
Capital Gain -10.61% 23% F 29% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -10.61% 25% F 30% F
Trailing 5 Years  
Capital Gain 69.53% 81% B- 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 69.53% 81% B- 76% C+
Average Annual (5 Year Horizon)  
Capital Gain 16.87% 87% B+ 85% B
Dividend Return 17.23% 88% B+ 84% B
Total Return 0.37% 36% F 23% F
Risk Return Profile  
Volatility (Standard Deviation) 15.40% 32% F 44% F
Risk Adjusted Return 111.89% 93% A 94% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.